Thymosin Beta-4 (TB-500): What Laboratory Research Shows

Thymosin beta-4 is a 43-amino-acid peptide of approximately 4.9 kDa, naturally occurring in many mammalian cell types and abundant in platelets. The synthetic peptide commonly referenced in laboratory work as TB-500 corresponds to the active region of full-length thymosin beta-4 and is used as a research reagent in cell-based assays.

The peptide's defining biochemical feature is a high-affinity G-actin sequestering domain, which underpins much of the in-vitro work conducted on cytoskeletal dynamics. TB-500 is supplied as a lyophilised powder for reconstitution prior to use in cell culture experiments.

A substantial body of published in-vitro research has used thymosin beta-4 to investigate actin polymerisation kinetics in cultured cells. Studies have characterised its binding constant for monomeric G-actin and the resulting effects on filament assembly observed in fluorescence microscopy and biochemical pull-down assays.

Additional cell-culture work has examined the peptide's role in migration assays using endothelial and epicardial cell lines, as well as in keratinocyte scratch-wound models. Reported effects on cytoskeletal remodelling, cell motility, and matrix metalloproteinase expression are documented in the peer-reviewed cell biology literature.

TB-500 is intended for in-vitro research use only. All cited findings derive from cell-culture or ex-vivo tissue work, and the compound is supplied as a reference peptide for laboratory investigation under the responsibility of the receiving researcher.